Market Commentary And Some Explanations For March 12, 2014. My Camera on laptop has issues and desktop has a flash media issue, so this is a black screen audio. In this audio, I explain my recent view on the over…
Video: Market Commentary for March 11 2014 – Why I Sold $SYN
Market Commentary for March 11 2014 – Why I Sold $SYN. In this video, I give my explanation for selling $SYN, and what I believe is going on with the markets, and why I feel caution is definitely warranted right…
Following The Smart Money: The Small Cap Biotech Investments Of Randal J. Kirk
Many might not be familiar with who Randal J. Kirk is, but he is an influential man in the small cap biotech investment world. He got his start in business in the early 1980’s and is now Chairman and Chief…
Biotech Catalyst Trade In Focus: Synthetic Biologics
Similar to how a blue-chip company might have an increase in stock price before an earnings call, small-cap developmental biotechs often increase in price before important clinical data releases, Advisory Committee Meetings (ADCOM), and U.S. Food and Drug Administration (FDA)…
Video: Market Commentary and Charts for Week March 10 2014
Market Commentary and Charts for Week March 10 2014. $SYN $PRAN $SGYP $ATRS $IBB $SPY $CERS $HALO reviewed plus some brief commentary on this week’s market action. Enjoy! Scott
Video: Synthetic Chart Explanation – Why Chart Pattern is Not A Double Top
Synthetic Chart Explanation – Why Chart Pattern is Not A Double Top. In this video, I demonstrate how the Synthetic chart could be misread as a double top formation pattern forming, which would be a bear signal. The Trend has…
Video: Market Commentary and Charts for March 5 2014
Market Commentary and Charts for March 5 2014. $SGYP, $RIGL, $ROSG, $SYN, $FRTD reviewed + additional market commentary and commentary on some of the stocks that I chart reviewed, Enjoy! Scott
I added more shares to $SYN. Target opinion = over $3.30
$SYN is presenting in investor conferences this week and next. The likeliness of a raise during this time is next to zero in my opinion. The Catalyst is drawing nearer and chart indicates to me a big move up is…
Cytokinetics: Small Cap Biotech Investment And Catalyst Trade In Focus
Written by Michael Kovar who has a position in $CYTK. Comments: Stock has gapped up a ton this morning, Scott and Kyle have no position, and never had a position in CYTK. Today, we are going to focus on a…
Trade Alert: We Bought $CYTR, Target opinion – $6.75-7
We bought CYTR and believe it can have a nice run in the short term. The chart is very bullish and the company is expecting Phase II data for INNO–206 aldoxorubicin for relapsed glioblastoma in 2014. Earlier in January the…
